ACM
CBIO

ADAR1 Capital Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

ADAR1 Capital Management’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,318
Closed -$82.6K – 215
2024
Q4 		$82.6K Buy
3,318
+2,861
+626% +$71.2K 0.02% 174
2024
Q3 		$7.72K Sell
457
-893
-66% -$15.1K ﹤0.01% 240
2024
Q2 		$38K Buy
+1,350
New +$38K 0.01% 187
2024
Q1 		– Hold
0
– – – 252